L-serine treatment may improve neurorestoration of rats after permanent focal cerebral ischemia potentially through improvement of neurorepair

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Sun, Li ^a   Qiang, Ren ^b   Yang, Yao ^a   Jiang, Zheng Lin ^a   Wang, Guo Hua ^a   Zhao, Guang Wei ^a   Ren, Tao Jie ^a   Jiang, Rui ^a   Xu, Li Hua ^a  

^a NANTONG UNIVERSITY   (China)

^b Third People's Hospital of Nantong   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE CELL ADHESION MOLECULE L1; NERVE GROWTH FACTOR; PROTEIN NOGO A; SERINE; TENASCIN; CENTRAL NERVOUS SYSTEM AGENTS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; BRAIN ISCHEMIA; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; MALE; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NEURAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; REPEATED DRUG DOSE; ANIMAL; BRAIN CIRCULATION; DRUG EFFECTS; INFARCTION, MIDDLE CEREBRAL ARTERY; MAZE TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM AGENTS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MAZE LEARNING; MICROVESSELS; NERVE REGENERATION; NEURAL STEM CELLS; RATS, SPRAGUE-DAWLEY; SERINE;

EID: 84899886759     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093405     Document Type: Article

References (54)

1. Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron 67: 181-198.
2. Macrae IM (2011) Preclinical stroke research-advantages and disadvantages of the most common rodent models of focal ischaemia. Br J Pharmacol 164: 1062-1078.
3. Broughton BR, Reutens DC, Sobey CG (2009) Apoptotic mechanisms after cerebral ischemia. Stroke 40: e331-e339.
4. Pandya RS, Mao L, Zhou H, Zhou S, Zeng J, et al. (2011) Central nervous system agents for ischemic stroke: neuroprotection mechanisms. Cent Nerv Syst Agents Med Chem 11: 81-97.
5. Sahota P, Savitz SI (2011) Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics 8: 434-451.
6. Picard-Riera N, Nait-Oumesmar B, Baron-Van Evercooren A (2004) Endogenous adult neural stem cells: limits and potential to repair the injured central nervous system. J Neurosci Res 76: 223-231. (Pubitemid 38451210)
7. Richardson RM, Singh A, Sun D, Fillmore HL, Dietrich DW, et al. (2010) Stem cell biology in traumatic brain injury: effects of injury and strategies for repair. J Neurosurg 112: 1125-1138.
8. Xiong Y, Mahmood A, Chopp M (2010) Neurorestorative treatments for traumatic brain injury. Discov Med 10: 434-442.
9. Xiong Y, Mahmood A, Chopp M (2010) Angiogenesis, neurogenesis and brain recovery of function. Curr Opin Investig Drugs 11: 298-308.
10. Thored P, Arvidsson A, Cacci E, Ahlenius H, Kallur T, et al. (2006) Persistent production of neurons from adult stem cells during recovery after stroke. Stem cells 24: 739-747. (Pubitemid 44464779)
11. Chiu SC, Hung HS, Lin SZ, Chiang E, Liu DD (2009) Therapeutic potential of olfactory ensheathing cells in neurodegenerative diseases. J Mol Med (Berl) 87: 1179-1189.
12. Shear DA, Tate CC, Tate MC, Archer DR, LaPlaca MC, et al. (2011) Stem cell survival and functional outcome after traumatic brain injury is dependent on transplant timing and location. Restor Neurol Neurosci 29: 215-225.
13. Vaquero J, Zurita M (2010) Functional recovery after severe CNS trauma: current perspectives for cell therapy with bone marrow stromal cells. Prog Neurobiol 93: 341-349.
14. Gögel S, Gubernator M, Minger SL (2011) Progress and prospects: stem cells and neurological diseases. Gene Ther 18: 1-6.
15. Jablonska A, Lukomska B (2011) Stroke induced brain changes: implications for stem cell transplantation. Acta Neurobiol Exp (Wars) 71: 74-85.
16. Leker RR (2009) Fate and manipulations of endogenous neural stem cells following brain ischemia. Expert Opin Biol Ther 9: 1117-1125.
17. Yoneyama M, Shiba T, Hasebe S, Ogita K (2011) Adult neurogenesis is regulated by endogenous factors produced during neurodegeneration. J Pharmacol Sci 115: 425-432.
18. Bednar MM, Perry A (2012) Neurorestoration therapeutics for neurodegenerative and psychiatric disease. Neurol Res 34: 129-142.
19. Seo JH, Cho SR (2012) Neurorestoration induced by mesenchymal stem cells: potential therapeutic mechanisms for clinical trials. Yonsei Med J 53: 1059-1067.
20. de Koning TJ, Klomp LW (2004) Serine-deficiency syndromes. Curr Opin Neurol 17: 197-204.
21. Wang GH, Jiang ZL, Chen ZQ, Li X, Peng LL (2010) Neuroprotective effect of L-serine against temporary cerebral ischemia in rats. J Neurosci Res 88: 2035-2045.
22. Ren TJ, Qiang R, Jiang ZL, Wang GH, Sun L, et al. (2013) Improvement in regional CBF by L-serine contributes to its neuroprotective effect in rats after focal cerebral ischemia. PLoS One 8: e67044.
23. de Koning TJ, Snell K, Duran M, Berger R, Poll-the BT, et al. (2003) L-Serine in disease and development. Biochem J 371: 653-661. (Pubitemid 36578864)
24. Kramer M, Dang J, Baertling F, Denecke B, Clarner T, et al. (2010) TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses. J Neurosci Methods 187: 84-89.
25. Wang XK, Feuerstein GZ, Xu L, Wang H, Schumacher WA, et al. (2004) Inhibition of tumor necrosis factor-α-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol Pharmacol 65: 890-896. (Pubitemid 38420494)
26. Chen J, Li Y, Wang L, Zhang Z, Lu D, et al. (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32: 1005-1011. (Pubitemid 32285175)
27. Germano AF, Dixon CE, d'Avella D, Hayes RL, Tomasello F (1994) Behavioral deficits following experimental subarachnoid hemorrhage in the rat. J Neurotrauma 11: 345-353. (Pubitemid 24282559)
28. Stout RW, Cho DY, Gaunt SD, Taylor HW, Baker DG (2001) Transcutaneous blood gas monitoring in the rat. Comp Med 51: 524-533. (Pubitemid 34073883)
29. Joshi CN, Jain SK, Murthy PS (2004) An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res Protoc 13: 11-17. (Pubitemid 38519594)
30. Manohar R, Appu Rao G, Appaji Rao N (1984) Kinetic mechanism of the interaction of D-cycloserine with serine hydroxymethyltransferase. Biochemistry 23: 4116-4122.
31. Ramesh KS, Appaji Rao N (1980) Purification and physicochemical, kinetic and immunological properties of allosteric serine hydroxymethyltransferase from monkey liver. Biochem J 187: 623-636.
32. Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 138: 155-175.
33. Duarte EP, Curcio M, Canzoniero LM, Duarte CB (2012) Neuroprotection by GDNF in the ischemic brain. Growth Factors 30: 242-257.
34. Duan SR, Wang J, Teng W, Xu R (2010) Expression of nestin and glial-derived neurotrophic factor in human endogenous neural stem cells following ischemia. Neurol Res 32: 835-840.
35. Chen B, Gao XQ, Yang CX, Tan SK, Sun ZL, et al. (2009) Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res 1284: 1-11.
36. Kameda M, Shingo T, Takahashi K, Muraoka K, Kurozumi K, et al. (2007) Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. Eur J Neurosci 26: 1462-1478. (Pubitemid 47416525)
37. Ichim G, Tauszig-Delamasure S, Mehlen P (2012) Neurotrophins and cell death. Exp Cell Res 318: 1221-1228.
38. Johanson C, Stopa E, Baird A, Sharma H (2011) Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus. J Neural Transm 118: 115-133.
39. Sun C, Zhang H, Li J, Huang H, Cheng H, et al. (2010) Modulation of the major histocompatibility complex by neural stem cell-derived neurotrophic factors used for regenerative therapy in a rat model of stroke. J Transl Med 8: 77.
40. Schmid RS, Maness PF (2008) L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol 8: 245-250.
41. Maness PF, Schachner M (2007) Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci 10: 19-26. (Pubitemid 46026522)
42. Schulz F, Lutz D, Rusche N, Bastús NG, Stieben M, et al. (2013) Gold nanoparticles functionalized with a fragment of the neural cell adhesion molecule L1 stimulate L1-mediated functions. Nanoscale 5: 10605-10617.
43. He X, Knepper M, Ding C, Li J, Castro S, et al. (2012) Promotion of spinal cord regeneration by neural stem cell-secreted trimerized cell adhesion molecule L1. PLoS One 7: e46223.
44. Cui YF, Xu JC, Hargus G, Jakovcevski I, Schachner M, et al. (2011) Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery after spinal cord injury in mice. PLoS One 6: e17126.
45. Chen J, Bernreuther C, Dihnë M, Schachner M (2005) Cell adhesion molecule L1-transfected embryonic stem cells with enhanced survival support regrowth of corticospinal tract axons in mice after spinal cord injury. J Neurotrauma 22: 896-906. (Pubitemid 41153874)
46. Chen J, Joon Lee H, Jakovcevski I, Shah R, Bhagat N, et al. (2010) The extracellular matrix glycoprotein tenascin-C is beneficial for spinal cord regeneration. Mol Ther 18: 1769-1777.
47. Andrews MR, Czvitkovich S, Dassie E, Vogelaar CF, Faissner A, et al. (2009) α9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J Neurosci 29: 5546-5557.
48. Meiners S, Mercado ML, Nur-e-Kamal MS, Geller HM (1999) Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance. J Neurosci 19: 8443-8453. (Pubitemid 30226763)
49. Joester A, Faissner A (2001) The structure and function of tenascins in the nervous system. Matrix Biol 20: 13-22. (Pubitemid 32178103)
50. Rigato F, Garwood J, Calco V, Heck N, Faivre-Sarrailh C, et al. (2002) Tenascin-C promotes neurite outgrowth of embryonic hippocampal neurons through the alternatively spliced fibronectin type III BD domains via activation of the cell adhesion molecule F3/contactin. J Neurosci 22: 6596-6609. (Pubitemid 35386416)
51. Abaskharoun M, Bellemare M, Lau E, Margolis RU (2010) Glypican-1, phosphacan/receptor protein-tyrosine phosphatase-ζ/β and its ligand, tenascin-C, are expressed by neural stem cells and neural cells derived from embryonic stem cells. ASN Neuro 2: e00039.
52. Wang T, Xiong JQ, Ren XB, Sun W (2012) The role of Nogo-A in neuroregeneration: a review. Brain Res Bull 87: 499-503.
53. Pernet V, Schwab ME (2012) The role of Nogo-A in axonal plasticity, regrowth and repair. Cell Tissue Res 349: 97-104.
54. Pernet V, Joly S, Dalkara D, Schwarz O, Christ F, et al. (2012) Neuronal Nogo-A upregulation does not contribute to ER stress-associated apoptosis but participates in the regenerative response in the axotomized adult retina. Cell Death Differ 19: 1096-1108.